WASHINGTON - Scientists from Hebrew University of Jerusalem claim to have identified a potential target that would help in development of novel oral drugs to control blood glucose levels in diabetes patients.
Lead researcher Prof. Shlomo Sasson of the Hebrew University School of Pharmacy has identified a molecular mechanism that regulates glucose transport in skeletal muscles.
During the study, researchers found that high levels of the carbohydrate D-xylose increased the rate of glucose entry into skeletal muscle cells in a non-insulin-dependent manner.
They then used it as a prototype molecule for the planning and synthesis of chemical derivatives that may act as potential drugs to lower blood glucose in type 2 diabetic patients.
Some of these derivatives increased significantly the rate of glucose transport in skeletal muscles at very low concentrations.
This effect was not achieved by mimicking the classical pathway of insulin action, but by activating the enzyme AMP-activated protein kinase (AMPK).
When activated, this enzyme increases the rate of glucose transport in skeletal muscles in the absence of insulin.
Therefore, compounds that activate this enzyme can be effective in insulin resistant type 2 diabetic patients or in those that fail to respond to conventional drug therapy.
This makes AMPK an extremely attractive target in the development of novel anti-diabetic drugs. (ANI)
Filed under Insulin, News | Tags: Washington | Comment Below
Related?
Cancer drug improves vision loss in diabetics, cataract surgery patientsAugust 1st, 2009 WASHINGTON - Researchers have found that bevacizumab medication, used to treat cancer, can help improve vision loss in diabetic patients as well as in people who have undergone cataract surgery. Use of bevacizumab (Avastin) can benefit diabetic patients with macular edema as well as people who develop cystoid macular edema after cataract surgery.
Anti diabetic drug effcetive in prostate cancer among men November 21st, 2008 Finland researchers have found diabetes drugs can be used to control risk of prostate cancer. The study concluded that men who had a history of taking any diabetes medication had a 16 percent lower risk of prostate cancer.
Diabetes Drugs May Lead To Bone FractureMay 11th, 2008 Thiazolidinediones, a widely used class of diabetes drugs can lead to bone fracture risk. Recent study in Switzerland proves that Pioglitazone and rosiglitazone, widely used drugs of the class, can lead to problems like slower bone formation and faster bone loss.
Better diet helps diabetics improve blood sugar controlJuly 2nd, 2009 SYDNEY - Providing intensive dietary advice improved blood sugar control in type 2 diabetics even when they were arguably on the best available medication, according to the latest research. The six-month study by Otago University's (OU) Edgar National Centre for Diabetes Research divided 87 high-risk diabetes patients into two groups.
Type 2 Diabetics May Enjoy Insulin Free Future June 17th, 2008 Researchers from the Veterans Affairs Northern California Health Care System in Martinez, California have found out that the type 2 diabetes patients may live an insulin free life. They can live a life on oral medications only.
Free Diabetes Medicines by University of MichiganApril 24th, 2006 Diabetics have to spend hundreds of dollars each month for the drugs they require. If they try to skip their medications, the results can be disastrous.
FDA advisers to vote on potential approval of 3 more anti-psychotic drugs for youngstersJune 10th, 2009 FDA panel to vote on psychiatric drugs for kidsWASHINGTON — Advisers to the Food and Drug Administration are scheduled to vote Wednesday on whether three powerful psychiatric drugs should be approved for children, despite side effects that can increase the risk of diabetes. A positive decision from FDA would expand the use of a class of drugs that accounted for more than $14.6 billion in sales last year, according to health care analysis firm IMS Health.
Allergy drugs may help reduce obesity and diabetesJuly 27th, 2009 LONDON - Drugs commonly used to treat allergies have been found to reduce obesity and type 2 diabetes in mice, say Harvard researchers. Lead researchers Guo-Ping Shi and Jian Liu focussed their study on inflammatory immune cells called mast cells, which facilitate healing in wounded tissue, primarily by increasing blood flow to the site.
